Jonathan McNeill, President and COO: Crescent Biopharma CBIO Sell · Filed 06/23

Trade details

Type: Insider sale
Amount: $369,676.51
Shares · price: 20,549 sh · $17.99 a share
Held after: 139,158 sh
Stock: Crescent Biopharma CBIO
Person: Jonathan McNeillPresident and COO
Trade date: 26/06/22
Filed: 26/06/23
Days to filing: 1 days

Sold 12.9% of holdings

Share of holding sold: 12.9%

Crescent Biopharma trades, last 26 weeks

What else happened in Crescent Biopharma around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Jonathan McNeill's recent trades

Jonathan McNeillPresident and COO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$75.8K
4,415 sh
$75.8K
Filed 09/17
Traded 09/18
Jonathan McNeillPresident and COO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$15.1K
804 sh
$15.1K
Filed 09/16
Traded 09/16
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$108K
2,400 sh
$108K
Filed 24/08/20
Traded 24/08/19
Jonathan McNeillChief Business Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$14K
305 sh
$14K
Filed 24/08/20
Traded 24/08/19
Jonathan McNeillChief Business Officer
SellDyne Therapeutics
Sell
Dyne Therapeutics
DYN
$57.1K
1,823 sh
$57.1K
Filed 24/06/11
Traded 24/06/11